The FDA has approved a selective serotonin-4 (5-HT4) receptor agonist to treat adults with chronic idiopathic constipation, a condition that affects 14% of the adult population.
The FDA has released a warning about the potential for an increase in disability in patients with multiple sclerosis who stop taking this immunosuppressant.
The FDA has reviewed and approved a qualified health claim for certain edible oils containing high levels of a monosaturated fat shown to have cardiovascular benefits.
The antibacterial drug is approved to treat travelers’ diarrhea, which is defined as having 3 or more unformed stools in 24 hours, in a person who is traveling.
In response to the release of a CDC report detailing increases in the use of e-cigarettes among youth in the US between 2011 and 2018, the FDA has released a statement detailing new limitations to the sale...
The American Thoracic Society says the FDA approved the asthma treatment with lack of consideration for patient safety and for a public policy process.
